FindTrial
Sign In

The study of Japanese lung cancer patients' preferences using data from discrete choice experiment

The study of Japanese lung cancer patients' preferences using data from discrete choice experiment - The study of Japanese lung cancer patients' preferences using data from discrete choice experiment

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000039087
Enrollment
200
Registered
2020-01-10
Start date
2020-01-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

None listed

Sponsors

Chugai pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)respondent of online survey from 25 November 2019 to 27 November 2019. 2) Lung cancer patients

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
relative importance of attributes and levels of drug therapy—

Secondary

MeasureTime frame
relation between patients' demographics and relative importance of attributes and levels of drug therapy—

Countries

Japan

Contacts

Public ContactYasuo Sugitani

Chugai pharmaceutical Co., Ltd. Clinical Development Div.

sugitaniyso@chugai-pharm.co.jp03-3273-0934

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026